SEC Comment Letter for enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053) (NVNO) — Jun 18, 2018
enVVeno Medical Corp (NVNO, NVNBW) (CIK 0001661053)
Date: June 18, 2018 · CIK: 0001661053 · Accession: 0000000000-18-018646
AI Filing Summary & Sentiment
File numbers found in text: 333-225570
Letter
June 18, 2018 Robert A. Berman Chief Executive Officer Hancock Jaffe Laboratories, Inc. 70 Doppler Irvine, California 92618 Re:Hancock Jaffe Laboratories, Inc. Registration Statement on Form S-1 Filed June 12, 2018 File No. 333-225570 Dear Mr. Berman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Division of Corporation Finance Office of Electronics and Machinery cc: Michael A. Hedge, Esq.
Show Raw Text
June 18, 2018
Robert A. Berman
Chief Executive Officer
Hancock Jaffe Laboratories, Inc.
70 Doppler
Irvine, California 92618
Re:Hancock Jaffe Laboratories, Inc.
Registration Statement on Form S-1
Filed June 12, 2018
File No. 333-225570
Dear Mr. Berman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Division of Corporation Finance
Office of Electronics and Machinery
cc: Michael A. Hedge, Esq.